ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As BCR-ABL transcript is solely expressed by the leukemic cells, its measurement by mean of quantitative PCR (Q-PCR) is considered one of the most sensitive and specific techniques to indirectly assess the tumor burden, and is the standard de facto for monitoring minimal residual disease in CML.